mohammadzadeh
1481
chronic
1488
million
2020b
taken
january
decree
exploited
512
teuber
abnormalitie
title
medicine
declared
shown
excluded
relevant
objective
berberi
phase
will
much
electronic
6gr
reduce
bay
going
studied
explained
part
compound
RCT
medika
s13063
kappa
diabetic
ffi
lifetime
activity
saradhi
pedraza
cause
retinopathy
upon
very
only
afsharpour
hariyono1
thank
ALA
ijem
type
problem
insan
melon
death
blind
characterized
avoid
masood
lipoeto
note
there
tinggi
component
LDL
giving
eur
raman
centella
TREATMENT
body'
288
park
appropriate
rate
western
genereal
ginseng
souza
246
OF
people
identify
source
III
meet
syzigium
nephropathy
brazil
outcome
demand
journal
hyperglycemia
meeting
provision
then
systematic
260
curcumin
china
asiatica
JBI
item
state
reache
gestational
john
reducing
show
mirfeizi
mehrzadi
001
associated
direct
olibanum
5992
tabel
should
discus
arilangga
hingest
380mg
involve
microvascular
blood
involving
sensorimotor
selected
kriteria
minister
preparation
better
due
samani
interest
percentage
honarvar
researcher
sun
chuengsamarn
mineral
marisol
clinical
fructose
properly
quality
screened
CM
hydrolyzed
food
index
diversity
vision
next
off
daily
similar
melatonin
2192
treating
indice
arzati
known
undiagnosed
oral
value
finding
unclear
FDS2
contain
112
DIABETIC
additional
OR
187
lanka
756
comparator
diabate
science
jayawardena
PICOS
rich
aimed
anti
reporting
hakimi
wahid
proces
102524
luechapudiporn
interact
lipid
input
table
samadi
2013
pharmacol
inflammatory
line
lipidic
rat
v9i3
oxidative
secondary
some
result
keyword
function
galappaththy
nurcahyani
360
alpha
text
MD
wa
set
country
herb
REFERENCES
improvement
detail
financial
agent
antioxidant
rattanamongkolgul
cultural
could
sage
analysi
validated
society
yoon
belief
387
research
koushan
hypoglycemic
NPDR
article
homeostasi
improve
between
aspect
manson
DMT2
complement
symptom
T2D
metabolism
inhibit
serum
NF
musharraf
cinnamomum
indicated
provider
parallel
vuksan
both
20434
silymarin
hariyono
CONFLICT
IJPHS
period
male
important
blindnes
hba1c
PAINFUL
ebsco
swaminathan
comparison
all
CAMBI
yarash
01013
regular
zhao
natazuka
qorbani
maithilikarpagaselvi
extract
les
remove
trial
would
mixture
cortez
user
european
practically
BMI
2019
IV
zhu
significantly
bee
total
1177
duplicated
formulary
publication
mind
limitation
navarrete
support
women
mancia
doe
factor
therapie
neuropathy
saedisomeolia
a1c
controlled
public
including
control
global
hasil
abundi
eligibity
why
february
saeed
1department
tree
supplementation
mortality
day
zachariah
authorized
lowering
pathology
disease
variou
linolenic
notwithstanding
lower
performing
antiamilase
must
mol
kidney
design
body
metabolic
2121
studie
below
hemoglobin
able
during
waterhouse
using
single
american
soo
efficacy
ddt
chosen
critical
herbal
haghighian
jung
prevention
eﬀect
united
other
turmeric
term
jombang
except
lipoic
namely
tocopherol
silymarine
university
berawi
608
PUFA
1642
wibowo2
google
cholesterol
another
108311
shidarti
valid
target
foot
zarezadeh
COMPARISON
mellitu
1007
attenuated
sekolah
1186
cardiovascular
inverse
2017
worker
significant
annona
versu
nano
peripheral
inclusion
nutr
scholar
INTRODUCTION
SAGE
malekpour
obtained
teixeira
impaired
phisalaphong
post
stres
1753
t2dmin
natural
morbidity
1gr
obtain
RESULT
induced
painful
secretion
cacy
516
khorshidi
glycosylated
investigated
ye
response
well
CAPSAICIN
recent
systolic
because
potential
micro
steinberg
individual
who
5582
TAC
according
plasma
level
lou
beljan
regulated
joint
capcaisine
2015
NEUROPATHY
faculty
nutrition
airlangga
hwa
database
turpentine
yekaninejad
carrying
jovanovski
exclude
analyzed
done
zeylanicum
2021
sectional
failure
npj
suitable
252
283
expected
indonesia
subjective
main
triple
OHA
2091
management
271
PRISMA
kinase
walnut
cohort
pre
world
federation
neto
disorder
marker
1016
alternative
experimental
105
840
khosravi
receiving
ortiz
II
shamsinejad
polyanthum
action
aghasadeghi
many
oxidant
conventional
life
194
supplement
complementary
11591
mohtashami
used
sanjari
figure
prediabete
month
MENKES
author
safi
being
ada
inventory
anthropometric
014
cremin
rivera
pubmed
way
model
categorized
july
possibly
2020
http
wrong
ctim
proquest
abelmoschu
antioxcidant
re
addition
medicinal
risk
124
selecting
remedie
esperanza
OIL
care
remaining
novel
identified
glucoherb
fast
gonza
ETDRS
exclussion
focusing
rezvani
244
patient
measured
beside
study
polyneuropathy
pharm
match
2020a
fundamental
appraisal
summarized
ARTICLE
T2DM
int
sharif
number
unchanged
jafarabadi
climate
developing
case
beri
IR
12342
lozada
organization
variety
sri
constantine
intake
resource
combination
population
beneficial
0000000000018553
abdollahi
HOMA
pharmaceutical
statu
about
380
300
0407
120
ginger
fremantle
nez
bolean
VEGF
their
3945
DISCUSSION
nurse
administration
therefore
krishna
2014
kangen
included
ranked
mozaffari
freita
increase
score
017
capacity
question
point
pressure
kesehatan
2156587217696929
carried
previou
huseini
providing
200
yaqub
flow
doi
2012
also
sitasi
tasked
edema
reviewer
related
published
improved
but
biol
small
therapeutic
over
antiglucosidase
widely
chem
largely
found
integerrima
seventh
672
eligibility
ilmu
association
agreement
prevent
accordance
dietary
dutie
DSPN
pay
34889
understand
like
1111
677
DM
katulanda
5812
biological
surbaya
glucose
willett
formulation
especially
include
ha
ranasinghe
heydari
vitamin
random
cut
mexico
plant
evidence
glutathione
nearly
severity
capsule
answer
guideline
preferred
through
oil
premakumara
insulin
prevalence
panax
caused
oxidation
australian
take
worldwide
our
500
based
1200
preserved
conflict
screening
developed
med
minimize
glycemic
AL
pharmacological
group
FBS
ijph
alencar
ORIGINAL
fasting
lez
prescription
large
nut
nezhad
relatively
pain
s00394
ecplored
2department
ceylon
araujo
medical
filtration
nuclear
field
treatment
caucasian
greater
such
e08
strategy
purpose
267
gobeille
analog
tourzani
diabre
mirrashidi
placebo
diabete
losse
decreased
stroke
than
scopu
exception
present
603
effective
republic
gingseng
mononuclear
p65
intervention
chaverri
category
assessed
indonesian
propoli
reduction
quasy
adjusting
traditional
2025
follow
elevated
economic
effort
time
purnamawati
novitasari
evaluate
propertie
antidiabetic
rapid
operator
creatinine
concentration
either
common
health
resistance
capsaicin
human
review
effectivenes
rahmanian
practice
somatic
chinese
record
framework
amputation
diagram
172171
jenkin
data
fed
fereydoonzadeh
afzali
TURPENTINE
clifford
theraphy
polyphenolic
muricata
general
mechanism
34172
131
welfare
wistar
century
joeliantina
after
agreed
cell
discussion
heart
five
bitter
topography
challenging
cinnamon
showed
international
javadi
checklist
india
moderate
opportunity
pandrial
nonproliferative
nettle
2007
adult
out
nurdin
second
reason
leave
gpx
khalili
quinquefoliu
stage
consist
size
endocrine
reported
metformin
vitro
khazaeli
hep
assessment
53mmol
cros
demographic
document
HK
makhdoomi
herbalism
1097
siassi
15gr
MATERIAL
macular
evaluation
conducted
org
yokozawa
quasi
mainstream
three
TOPICAL
2018
143
acid
safety
identifying
use
sugar
publishing
week
activitie
518
prospective
damasceno
384
2016
two
cendekia
ciol
deemed
crossover
each
carry
momordica
tannin
STZ
controlling
davi
role
start
verum
therapy
nursing
involvement
pan
bia
investigation
2009
attention
asses
it
javad
aim
INTEREST
ahmad
mixed
profile
protocol
resulted
anthropomorphic
200gr
peroxidase
weeratunga
tropical
CONCLUSION
manuel
pharmacology
weight
criteria
triglyceride
full
identification
randomized
proboningsih
observed
martı
anderson
suplementation
sridhar
topical
hiratani
growth
018
abstrak
consistent
highest
established
253
complication
searching
mean
numerou
however
indonesia'
along
not
karyu
meta
double
019
compared
characteristic
perform
jirawatnotai
one
peanut
remain
minimum
did
ACKNOWLEDGMENT
garcia
find
whortleberry
rao
METHODS
macrovascular
selection
estimated
root
adolescent
effect
charantia
beta
reduced
kyoung
serine
blinded
remained
499
potentiated
more
year
search
1204
inclussion
glomerular
asadi
166
consumption
before
regarding
hashemipour
134
soursop
suhendra
considered
abstract
september
most
phenolic
analyse
high
syzygium
900
manihot
agung
integr
had
first
pegagan
jika
analyze
2040